Details for New Drug Application (NDA): 022328
✉ Email this page to a colleague
The generic ingredient in INTERMEZZO is zolpidem tartrate. There are thirty-three drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the zolpidem tartrate profile page.
Summary for 022328
Tradename: | INTERMEZZO |
Applicant: | Purdue Pharma |
Ingredient: | zolpidem tartrate |
Patents: | 4 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 1.75MG | ||||
Approval Date: | Nov 23, 2011 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 15, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | METHOD FOR TREATING INSOMNIA | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 16, 2025 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | METHOD FOR TREATING INSOMNIA | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 20, 2029 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | METHOD OF TREATING MIDDLE-OF-THE-NIGHT INSOMNIA |
Complete Access Available with Subscription